pre-clinical activity of ucartcs1 in multiple myeloma
Published 1 year ago • 120 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
4:00
potent pre-clinical and early phase activity of inobrodib in multiple myeloma
-
2:11
synergistic activity of alnuctamab and celmods in multiple myeloma preclinical models
-
2:17
session highlights: practical aspects of immunotherapy in multiple myeloma
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
0:52
the importance of incorporating frailty assessment tools in clinical practice for multiple myeloma
-
18:01
1 year anniversary with monoclonal gammopathy (mgus)
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
2:53
triplet regimens for treating multiple myeloma at early relapse
-
2:13
founding precision therapy for 1q-amplified multiple myeloma
-
1:15
from clinical trials to clinical practice: upcoming drug developments in multiple myeloma
-
3:06
phase i study of hpn217 in patients with r/r multiple myeloma
-
1:01
car-t: myeloma toxicities
-
1:53
the future of multiple myeloma treatment
-
3:05
prognostic scoring system after transplantation in myeloma: predicting early relapse
-
2:11
overview and rationale for practical workshops at the 2016 european multiple myeloma academy (emma)
-
4:26
outcomes of ird in r/r multiple myeloma in routine clinical practice
-
2:18
blood screening for mgus: preventing progression with promise
-
2:53
key multiple myeloma data from asco 2020
-
1:37
the next steps and updated guidelines for the use of mrd concepts in multiple myeloma
-
3:09
immunotherapy in myeloma - where are we?
-
2:15
myeloma treatment and management in the covid era